Physician
Internal Medicine
Dr. Sidney E. Grossberg, MD
|
|
Give Review
Sidney Grossberg works in the field of Internal Medicine. He attended Emory University School of Medicine. Emory University School of Medicine is ranked 23 in research and 42 in primary care medicine Sidney Grossberg has written publications. He has 60 publications published with PubMed. The lastest publication is: 'A novel bioassay for the determination of neutralizing antibodies to IFN-beta1b.'
Publications
- Partial molecular cloning of the JHK retrovirus using gammaretrovirus consensus PCR primers.
- Frequency and Magnitude of Interferon β Neutralizing Antibodies in the Evaluation of Interferon β Immunogenicity in Patients with Multiple Scle...
- Quantification of the neutralization of cytokine biological activity by antibody: the ten-fold reduction bioassay of interleukin-6 as growth factor.
- The neutralization of interferons by antibody III. The constant antibody bioassay, a highly sensitive quantitative detector of low antibody levels.
- How the American Society for Virology was founded.
- Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
- Perspectives on the neutralization of interferons by antibody.
- Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cel...
- Age-related cellular resistance of the chicken embryo to viral infections. II. Inducible resistance produced by influenza virus and Escherichia coli.
- Age-related cellular resistance of the chicken embryo to viral infections. I. Interferon and natural resistance to myxoviruses and vesicular stomatitis virus.
- Interferon bioassay: reduction in yield of myxovirus neuraminidases.
- A sensitive interferon assay for many species of cells: encephalomyocarditis virus hemagglutinin yield reduction.
- Molecular and biologic characterization of recombinant interferon-alpha2b.
- The interferons and their inducers: molecular and therapeutic considerations. 2.
- Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.
- Phase IA/IB evaluation of mammalian cell-derived glycosylated recombinant human interleukin (SIGOSIX) before and after cytotoxic chemotherapy.
- Interferon and antibody titrations using haemagglutinating Togaviridae and trypsinized human erythrocytes.
- Comparative enzyme kinetics of influenza neuraminidases with the synthetic substrate methoxyphenylneuraminic acid.
- The interferons and their inducers: molecular and therapeutic considerations. 1.
- Inhibition of the differentiation of 3T3-L1 cells by interferon-beta and difluoromethyl ornithine.
- Clostridium difficile toxin A therapy for HCT 116 human colon cancer in nude mice.
- Interferon bioassay methods and the development of standard procedures: a critique and analysis of current observations.
- Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.
- Cytotoxicity of Clostridium difficile toxin A for human colonic and pancreatic carcinoma cell lines.
- Immunochemical characterization of antigenic domains on human interferon-beta: spatially distinct epitopes are associated with both antiviral and antiproliferative act...
- Interferon receptors and their role in interferon action.
- Inhibitory effects of mitochondrial metabolic inhibitors on interferon action.
- Quantitative analysis of mouse interferon-beta receptor-mediated endocytosis and nuclear entry.
- The cellular internalization of recombinant gamma interferon differs from that of natural interferon gamma.
- Standardization of cytokines and their ligands.
- Phase I trial of an oral immunomodulator and interferon inducer in cancer patients.
- The effects of interferon-alpha on the production and action of other cytokines.
- High levels of circulating neutralizing antibody in normal animals to recombinant mouse interferon-beta produced in yeast.
- Antibodies that neutralize human beta interferon biologic activity recognize a linear epitope: analysis by synthetic peptide mapping.
- Antiviral and antidifferentiative activities of interferon beta and gamma in relation to their induction of double-stranded RNA-dependent protein kinase activity in 3T...
- Absence of biological effects of orally administered interferon-beta ser.
- Immunogenicity of an interferon-beta1a product.
- The neuraminidase yield-reduction bioassay of human other interferons.
- Quantitative liquid-phase chemiluminescence ELISA: detection of subtle epitope differences in HuIFN-beta.
- Mapping of IFN-beta epitopes important for receptor binding and biologic activation: comparison of results achieved using antibody-based methods and alanine substituti...
- Recent progress in interferon research: molecular mechanisms of regulation, action, and virus circumvention.
- Transmissible retrovirus in Epstein-Barr virus-producer B95-8 cells.
- Analysis of antigenic domains on natural and recombinant human IFN-beta by the inhibition of biologic activities with monoclonal antibodies.
- A novel bioassay for the determination of neutralizing antibodies to IFN-beta1b.
- Reduced effectiveness of long-term interferon-beta treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis c...
- What's new in microbiology ... emerging infections.
- Quantification of neutralizing antibodies to human type I interferons using division-arrested frozen cells carrying an interferon-regulated reporter-gene.
- Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex.
- Ruthenium red preserves glycoprotein peplomers of C-type retroviruses for transmission electron microscopy.
- Synergy, activity and tolerability of zidovudine and interferon-alpha in patients with symptomatic HIV-1 infection: AIDS Clincal Trial Group 068.
- The expression of potency of neutralizing antibodies for interferons and other cytokines.
- A human B-lymphoblastoid cell line constitutively producing Epstein-Barr herpesvirus and JHK retrovirus.
- Constitutive production of a murine retrovirus in the human B-lymphoblastoid cell line, DG-75.
- The neutralization of interferons by antibody. II. Neutralizing antibody unitage and its relationship to bioassay sensitivity: the tenfold reduction unit.
- The neutralization of interferons by antibody. I. Quantitative and theoretical analyses of the neutralization reaction in different bioassay systems.
- Urea-nuclease treatment of concentrated retrovirions preserves viral RNA and removes polymerase chain reaction-amplifiable cellular RNA and DNA.
- Neutralization of the biological activity of cytokines and other protein effectors by antibody: theoretical formulation of antibody titration curves in relation to ant...
- Interferon-beta antibodies: implications for the treatment of MS.
- Validating parameters of a luciferase reporter gene assay to measure neutralizing antibodies to IFNbeta in multiple sclerosis patients.
Schools
Emory University
Doctors Specialties
- Medical Microbiology
- Internal Medicine
Accepted Insurances
Education
-
Duke University Hospital -
Emory University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Charlene Vander Zanden, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Rebekah D. Schroeder
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dafaallah H. Osman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunitha Gundamraj, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Pryba, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fernando T. Itable, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paras M. Patel, MD |